Terms: = Ovarian cancer AND KDM5A, RBBP2, 5927, JARID1A, ENSG00000073614
6 results:
1. Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan-cancer analysis.
Sun Z; Bai C; Su M; Tang H; Wu X; Wang Y; Bao H; Liu X; Wu X; Shao Y; Xu B
Mol Oncol; 2023 Sep; 17(9):1917-1929. PubMed ID: 37013911
[TBL] [Abstract] [Full Text] [Related]
2. kdm5a Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in ovarian cancer.
Liu H; Lin J; Zhou W; Moses R; Dai Z; Kossenkov AV; Drapkin R; Bitler BG; Karakashev S; Zhang R
Cancer Immunol Res; 2022 Aug; 10(8):1028-1038. PubMed ID: 35726891
[TBL] [Abstract] [Full Text] [Related]
3. Defining prognostic factors in older patients with endometrial cancer.
Yucel Celik O; Unsal M; Kilic F; Unsal P; Aytekin O; Cakir C; Kimyon Comert G; Turkmen O; Turan T
Ir J Med Sci; 2022 Jun; 191(3):1123-1131. PubMed ID: 34101103
[TBL] [Abstract] [Full Text] [Related]
4. Microscopic extraovarian sex cord proliferation: report of a case with bilateral Fallopian tube involvement and a comprehensive molecular analysis.
Dundr P; Věcková Z; Tichá I; Hojný J; Němejcová K; Bártů M
Pol J Pathol; 2020; 71(2):175-180. PubMed ID: 32729308
[TBL] [Abstract] [Full Text] [Related]
5. kdm5a promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance.
Feng T; Wang Y; Lang Y; Zhang Y
Mol Med Rep; 2017 Sep; 16(3):3573-3580. PubMed ID: 28714030
[TBL] [Abstract] [Full Text] [Related]
6. Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.
Katoh M
Expert Rev Proteomics; 2015 Jun; 12(3):317-28. PubMed ID: 25835095
[TBL] [Abstract] [Full Text] [Related]
